Neuro-Oncological Ventral Antigen 2 (NOVA2) Peptide
NOVA2
Reactivity: Mammalian
Host: Synthetic
WB, BP, IHC
-
- Target See all NOVA2 products
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Western Blotting (WB), Blocking Peptide (BP), Immunohistochemistry (IHC)
- Sequence
- EPEQVHKAVS AIVQKVQEDP QSSSCLNISY ANVAGPVANS NPTGSPYASP
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NOVA2 antibody,
Alternative Names: NOVA2 control peptide, NOVA2 antibody Blocking Peptide, Anti-NOVA2 Blocking Peptide, Neuro-Oncological Ventral Antigen 2 Blocking Peptide, NOVA2, NOVA-2, NOVA 2, NOVA-2 Blocking Peptide, NOVA 2 Blocking Peptide - Purification
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
- Background
- NOVA2 may regulate RNA splicing or metabolism in a specific subset of developing neurons. It binds single strand RNA.
- Molecular Weight
- 54 kDa
-
You are here:
